Back to search

Article

Specific Aneuploidies Predict Immune Evasion and Poor Immunotherapy Response in Melanoma

2026-04-15

Abstract excerpt

Melanoma is one of the leading cancer types treated with immune checkpoint blockade (ICB), yet a substantial proportion of patients fail to respond. While tumor mutational burden and PD-L1 expression are established ICB biomarkers, they leave large gaps in predictive accuracy. Somatic copy number alterations (SCNAs) are pervasive in melanoma but their role in shaping the tumor immune microenvironment (TME) and pre...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c65c37dc-21af-5f16-862d-f4a81dcbbc13
DOI
10.64898/2026.04.12.718039
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Specific Aneuploidies Predict Immune Evasion and Poor Immunotherapy Response in MelanomaDOI 10.64898/2026.04.12.718039
Select a neighboring publication to make it the new centre.